Navigation Links
Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum
Date:10/23/2008

PRINCETON, N.J., Oct. 23 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the BIO Investor Forum in San Francisco. Mr. Jackson will provide a corporate overview and an update on the company's clinical development programs. The presentation will be held on Wednesday, October 29, 2008 at 1:45 PM PDT in the Marina Room of the Palace Hotel.

The company is also pleased to announce that Dr. Arthur Louie, chief medical officer, has been invited to participate in a therapeutic workshop titled, "Pre-ASH Primer: Hematology Heavy Hitters Discuss What's on the Horizon." The workshop will be held on Thursday, October 30, 2008 at 9:30 AM PDT in the Twin Peak South Room of the Palace Hotel.

About Celator

Celator Pharmaceuticals, Inc., with locations in Princeton, NJ, and Vancouver, BC, is a privately held pharmaceutical company developing new and more effective therapies to treat cancer. CombiPlex(R), the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies based on identifying a fixed, synergistic ratio of the drugs pre-clinically, incorporating that ratio in a drug delivery vehicle and maintaining the ratio in patients. The company pipeline includes: CPX-1 (a liposomal formulation of irinotecan:floxuridine), currently in a Phase 2 trial in patients with colorectal cancer; CPX-351 (a liposomal formulation of cytarabine:daunorubicin), currently in a Phase 1 trial in patients with advanced leukemia; CPX-571 (a liposomal formulation of irinotecan:cisplatin), a preclinical stage compound; and multiple research programs. Based on the applications of CombiPlex, Celator is positioned to advance a broad pipeline of combination therapies involving both previously approved and novel drug agents. For more information, please visit the company's website at http:/
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention
2. Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
3. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
4. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
5. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
6. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
7. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
8. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
10. Amylin Pharmaceuticals Reports Third Quarter Financial Results
11. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., NEW YORK, Dec. 2 Near...licy makers, and funders today convened to explore...ng strategies at the inaugural Partnering for Cur...based center of the Milken Institute, convened Pa...laborations needed to turn a scientific discovery ...
(Date:12/2/2009)..., LELYSTAD, The Netherlands, December 2 /PRNew...d biotechnology company focusing on protein mimick...eutics today announced that it,has appointed Wim E..., Dr. Mol will be responsible for all of Pep...nt and strategic direction of the company. He brin...
(Date:12/2/2009)..., NANJING, China, Dec. 2 /PRNewswire-Asia/ -...Company") (NYSE: SCR ), a leading pharmaceutical...uring, and marketing of branded,generic and propri...at 105 of,its drugs have been included in China,s ...as issued by China,s Ministry of Human Resources a...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he...unched his redesigned website at www.DrKerrySolom... Group. Dr. Solomon is a proven LASIK, lens impla...ssionally recognized for his substantial contribut...s a member of Trusted LASIK Surgeons, which screen...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
..., AMSTERDAM, January 22 Avantium Technologies...stallization processes for the,pharmaceutical indu...rystalline. , The Crystalline has been designe...arn as much as possible about a drug candidate ear...oud to launch its next system in crystallization r...
..., , Troy, N.Y. Researchers at Rensselaer Polytec...ntrolling the nature of graphene, bringing academi...izing the mass production of graphene-based nanoel...carbon, was discovered in 2004 and is considered a...mental building blocks of nanoelectronics. , With...
..., DURHAM, N.C. -- After announcing last April a m...merous and well-aligned carbon cylinders only a fe...sts has now modified that process to create exclus...ed carbon nanotubes. , The achievement paves the ...uits at the ultra-small billionths of a meter scal...
Other Biology Technology:Avantium Launches the Crystalline, a New Parallel System for Crystallization Research 2Light-speed nanotech: Controlling the nature of graphene 2Semiconducting nanotubes produced in quantity at Duke 2Semiconducting nanotubes produced in quantity at Duke 3
(Date:12/2/2009)... The Manpei Suzuki Diabetes Foundation is pleased...Prize: Donald F. Steiner, MD, A. N. Pritzker Disti...f Medicine and Biochemistry and Molecular Biology,...s inaugurated in 2008 to commemorate the 15th anni...honoring those who have enlightened researchers in...
(Date:12/2/2009)..., Scientists are reporting the first identificat...transformation that changes harmless marine bacter...r study appears in ACS, Environmental Science & T...n and colleagues note that bleaching already has d...fs, and scientists are searching for ways to slow ...
(Date:12/2/2009)..., , REDWOOD SHORES, Calif. and PA...Communication Intelligence Corporation ("CIC") (OT...ctronic signature solutions for business process a...nized leader** in biometric signature verification... International Electronic Document Management (EDM...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4West to Host 2009 Second Quarter Conference Call 52897 1West to Host 2009 Second Quarter Conference Call 52897 2Hard to Treat Diseases 28HTDS 29 To Re Release European TV Segment In N America For Potential Treatment Of MS 52894 1Hard to Treat Diseases 28HTDS 29 To Re Release European TV Segment In N America For Potential Treatment Of MS 52894 2Hard to Treat Diseases 28HTDS 29 To Re Release European TV Segment In N America For Potential Treatment Of MS 52894 3Hard to Treat Diseases 28HTDS 29 To Re Release European TV Segment In N America For Potential Treatment Of MS 52894 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 1Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 2Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 5Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 6Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 7Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results 52892 8
...rnational,s MobileCop(R) and DaProSystems, Public ... Data and a Link to Dispatchers , , WALL, N.J., A...n Board: BKYI), a leader in finger-based biometric...ns and its partner, DaProSystems of Roanoke, Virgi... announced nine recent mobile data software contra...
...ientist from Johns Hopkins has convinced an intern... find new cancer biomarkers and instead begin a 7,...tific articles already published to assemble, deco... furtive presence of pancreatic cancer. , With l...expensive testing that needs to be done before any...
...Mass., USA (April 6, 2009) Cell Press, an imprint...urnal, Cell , as well as Current Biology and Th... among the Special Library Association,s (SLA) Top...century. , The Top 100 list is compiled by the 68...iences Division (DBIO) on the most influential jou...
Other Biology News:Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 2Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 3Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution 4Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection 2Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection 33 prominent Cell Press journals named among the 100 most influential journals in past 100 years 2
...rray Dot Blot Kits overcome this limitation and of...er a wide range in low-density protein array (96- ...for performing reverse-phase protein arrays and fo...f low abundant antigens. Protein Detector kits are...
...croarray Slide features an ultra-thin nitrocellulo...53; Slide is the first protein microarray slide to...thin film with low,background fluorescence providi...53; Slide can be used for a variety of assays, suc...
...tabilizer is an aqueous solution that contains a p...zing chemicals in a MES buffer (4-Morpholine-ethan...ns a combination of 0.02% methylisothiazolone and ...Zyme AP Conjugate Stabilizer is formulated specifi...
...valuable tool for removing SDS detergent from prot...mples imparts a negative charge to the tightly bou...y during digestion, and suppresses ion signals and...alyses. We recommend that SDSaway be used with Pr...
Biology Products: